Petra Kaufmann

Insider Reports History

Entity
Individual
Location
C/O Affinia Therapeutics Inc., 43 Foundry Ave, Suite 120, Waltham, MA
Signature
/s/ Christopher Verni, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Petra Kaufmann:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Vigil Neuroscience, Inc. Chief Medical Officer Stock Option Grant (Right to Buy) 330K Mar 18, 2024 Direct

Insider Reports Filed by Petra Kaufmann

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VIGL Vigil Neuroscience, Inc. Mar 18, 2024 1 $0 4 Mar 20, 2024 Chief Medical Officer
VIGL Vigil Neuroscience, Inc. Mar 18, 2024 0 $0 3 Mar 20, 2024 Chief Medical Officer